跳至主要内容
临床试验/ACTRN12620000762954
ACTRN12620000762954招募中未知

Endoscopic Ultrasound Molecular Evaluation of Pancreatic Cancer Trial

Dr Daniel Croagh0 个研究点目标入组 150 人开始时间: 2020年7月27日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Adults, age 18 years or over, male or female
  • 2. Locally advanced (unresectable) or metastatic biopsy-proven pancreatic ductal adenocarcinoma (PDAC) based on the NCCN guidelines version 2, 2017 criteria or recurrent disease
  • 3. Tumour tissue available for DNA/RNA extraction
  • 4. ECOG Performance Status 0-2
  • 5. Suitability for chemotherapy
  • 6. Provision of informed consent for participation in the study
  • 7. Life expectancy of at least 3 months from the time of screening as judged by screening investigator.

排除标准

  • 1. Operable or borderline resectable pancreatic cancer
  • 2. Neuroendocrine pancreatic cancers
  • 3. Evidence of systemic disease (cardiovascular, respiratory, renal, hepatic, etc.) that would preclude chemotherapy.
  • 4. Serious medical or psychiatric conditions that might compromise protocol-based management as judged by investigator

研究者

发起方
Dr Daniel Croagh

相似试验